Inspection Record

Canadian Blood Services — Health Canada Inspection Findings

Health CanadaInspected 2022-03-22 5 findingsDeviation, CAPA, and investigationMaterial and supplier controlEquipment and facilityLaboratory and QC controlsOther quality system

View the regulator's official source The source document is always the basis for judgement.

Findings

1Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate.

2Material and supplier control

The identification, quarantine, and/or disposal of rejected materials was inadequate.

3Equipment and facility

The temperature and/or humidity control was inadequate. The maintenance of records was inadequate.

4Laboratory and QC controls

The quality control department did not undertake all of the required activities.

5Other quality system

The assessment, documentation, and/or procedures for considering the resale of returned drugs were inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2022-03-22. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Canadian Blood Services company profile — full history Health Canada documents, 2022 Go to Findings search